This finding offers a prospective insight for the elevated IL-6 cytokines levels observed in both the sera of breast cancer patients as well as at the edges of breast tumour masses (Hou et al., 2018; Johnson et al., 2018; Chen et al., 2022; Manore et al., 2022). Here, IL6 is linked to breast neoplasm.